Fidelity Investments’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1
Closed -$14 5320
2024
Q4
$14 Sell
1
-1
-50% -$15 ﹤0.01% 5409
2024
Q3
$32 Sell
2
-9
-82% -$142 ﹤0.01% 5259
2024
Q2
$169 Buy
11
+10
+1,000% +$152 ﹤0.01% 4934
2024
Q1
$16 Sell
1
-1
-50% -$16 ﹤0.01% 5217
2023
Q4
$29 Buy
+2
New +$28 ﹤0.01% 5113
2021
Q3
Sell
-2
Closed 4358
2021
Q2
$0 Buy
+2
New +$55 ﹤0.01% 4256

Other funds holding BMEZ

Fidelity Investments's BMEZ Position: Q1 2025 in Review

Fidelity Investments sold out of BlackRock Health Sciences Trust II (BMEZ) in Q1 2025, closing a stake of 1 share — an estimated $14 sold.

Fidelity Investments first reported a position in BMEZ in Q2 2021 and held it in 6 quarters. The position peaked at $169 in Q2 2024. 98 funds tracked by Wall St. Rank hold BMEZ as of Q1 2025.

  • Fidelity Investments reported no remaining BlackRock Health Sciences Trust II position as of Q1 2025 after selling out during the quarter.
  • Fidelity Investments sold 1 BlackRock Health Sciences Trust II share in Q1 2025, an estimated $14.
  • Fidelity Investments first reported a position in BlackRock Health Sciences Trust II in Q2 2021 and held it in 6 quarters.
  • Fidelity Investments's BlackRock Health Sciences Trust II position peaked at $169 in Q2 2024.
  • 98 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q1 2025.

Based on Fidelity Investments's 13F filing for Q1 2025, filed 12 May 2025.